Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study
1. 系统已在2026-08-30 15:58:56对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.jaad.2026.05.048
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S019096222602726X
其他信息:
出版社: Elsevier BV
作者: Jennifer Soung; Yong Cui; Robert Bissonnette; Mark G. Lebwohl; Álvaro González-Cantero; Andreas Pinter; Phoebe Rich; Vimal H. Prajapati; Megan Miller-Kassamali; Joseph Cafone; Jingzhi Jiang; Shu Li; Ya-Wen Yang; Andrew E. Pink

